Verano Holdings (VRNO) Free Cash Flow Growth (3y) (2024 - 2026)
Verano Holdings (VRNO) Free Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 39.19% |
| 10 | Verano Holdings | 2.00 Bn | 1.92 Bn | 98.98 Mn | -23.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.98% |
| Dec 31, 2025 | -67.92% |
| Sep 30, 2025 | 30.51% |
| Jun 30, 2025 | -80.04% |
| Mar 31, 2025 | 4.44% |
| Dec 31, 2024 | 28.79% |
| Sep 30, 2024 | -41.24% |